Aspirin: 1A @ 125.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3194, doi. 10.1093/eurheartj/ehac416
- By:
- Publication type:
- Article
Works matching IS 0195668X AND DT 2022 AND VI 43 AND IP 34
Results: 17
1
2
Screening, diagnosis, and treatment of familial hypercholesterolaemia: a call to action.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3185, doi. 10.1093/eurheartj/ehac479
- By:
- Publication type:
- Article
3
Is there an optimal diet for primordial prevention of atherosclerosis?
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3189, doi. 10.1093/eurheartj/ehac434
- By:
- Publication type:
- Article
4
Danish scientist wins prestigious prize for piecing together the facts about remnant cholesterol.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3192, doi. 10.1093/eurheartj/ehac429
- By:
- Publication type:
- Article
5
Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3196, doi. 10.1093/eurheartj/ehac424
- By:
- Publication type:
- Article
6
Right atrial thrombus in transit.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3274, doi. 10.1093/eurheartj/ehac346
- By:
- Publication type:
- Article
7
Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3227, doi. 10.1093/eurheartj/ehac339
- By:
- Publication type:
- Article
8
From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3240, doi. 10.1093/eurheartj/ehac338
- By:
- Publication type:
- Article
9
More than myocarditis, a rare adverse effect after the ChAdOx1 vaccine.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
10
Screening in children for familial hypercholesterolaemia: start now.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3209, doi. 10.1093/eurheartj/ehac224
- By:
- Publication type:
- Article
11
Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3258, doi. 10.1093/eurheartj/ehab705
- By:
- Publication type:
- Article
12
Statin intolerance: how common is it and how do we work with patients to overcome it?
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3224, doi. 10.1093/eurheartj/ehac156
- By:
- Publication type:
- Article
13
Underdiagnosis of familial hypercholesterolaemia: innovation is overdue.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3255, doi. 10.1093/eurheartj/ehab869
- By:
- Publication type:
- Article
14
dawn of a new era of targeted lipid-lowering therapies.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3198, doi. 10.1093/eurheartj/ehab841
- By:
- Publication type:
- Article
15
Risk of remnants and remnant risk in peripheral artery disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3270, doi. 10.1093/eurheartj/ehab815
- By:
- Publication type:
- Article
16
Prevalence of statin intolerance: a meta-analysis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3213, doi. 10.1093/eurheartj/ehac015
- By:
- Publication type:
- Article
17
Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3243, doi. 10.1093/eurheartj/ehab770
- By:
- Publication type:
- Article